Researchers at the University of Oregon have developed an artificial intelligence-based tool designed to predict the behavior of new drug molecules prior to laboratory testing.
This tool aims to provide insights into how hypothetical drugs might perform, which could lead to a reduction in the number of drug candidates that fail during development.
The advancement could represent a significant step forward in the pharmaceutical industry, where many potential drugs do not make it to market due to unforeseen issues.